                               SEQUENCE LISTING

<110> JANSSEN BIOTECH, INC.
	RYAN, DAPHNE ANN SALICK 
      KEHOE, JOHN
      WHEELER, JOHN
      YANG, CHUNLIN
      CREASEY, ALBA
 
<120> AFFINITY PEPTIDES TOWARD INFLIXIMAB

<130> RTX5041WOPCT

<140> To Be Assigned 
<141> 2013-05-14

<150> 13/474,056
<151> 2012-05-17

<160> 32    

<170> PatentIn version 3.5

<210> 1
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Ala Gly Trp Thr Val Ala Tyr Val Pro Pro Gly Pro Ser Tyr Ala Thr 
1               5                   10                  15      


Ser 
    


<210> 2
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Ala Gly Tyr Val Cys Asp Pro Ala Gly Pro Asn Cys Trp Ala 
1               5                   10                  


<210> 3
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Ala Gly Thr Tyr Cys His Pro Asp Gln Leu Arg Asn Leu Cys Pro Val 
1               5                   10                  15      


<210> 4
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Ala Gly Val Thr Cys Arg Met Thr Glu Tyr Gly Pro Met Cys Pro Thr 
1               5                   10                  15      


<210> 5
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Ala Gly Asn Arg Cys Ala Tyr Ala Ala Gly Thr Ile Gln Cys Phe Pro 
1               5                   10                  15      


<210> 6
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Ala Gly Glu Ile Cys Tyr Trp His Asp Thr Asp Trp Val Cys Thr Glu 
1               5                   10                  15      


<210> 7
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Ala Gly Thr His Cys Ser Tyr Val Leu Gly Arg Ile Glu Cys Leu Pro 
1               5                   10                  15      


<210> 8
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Ala Gly Asn Tyr Cys His Pro Asp Gln Leu Ser Gln Phe Cys Ala Arg 
1               5                   10                  15      


<210> 9
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Ala Gly Val Ala Cys His Ser Thr Gly Thr Asn Ile Tyr Thr Cys Thr 
1               5                   10                  15      


Tyr 
    


<210> 10
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Ala Gly Val Trp Cys Gly Asp Glu Thr Leu Pro Pro Ser Ile Cys Phe 
1               5                   10                  15      


Arg 
    


<210> 11
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Ala Gly Ser Leu Cys His Thr Val Gly Ser Gly Ile Tyr Asn Cys Thr 
1               5                   10                  15      


Lys 
    


<210> 12
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Ala Gly Ile Gln Cys His Asp Val Gly Ala Gly Val Val Thr Cys Thr 
1               5                   10                  15      


Tyr 
    


<210> 13
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Ala Gly Pro Pro Cys Ile Val Thr Gln Leu Ser Asp Leu Ser Phe Cys 
1               5                   10                  15      


Ala Pro 
        


<210> 14
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Ala Gly Ala Arg Cys Ala Pro Ala Phe Asp Ala Asn Trp Leu Ile Cys 
1               5                   10                  15      


Ser Asn 
        


<210> 15
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Ala Gly Pro Pro Cys Ala Ala Ala Met Ala Gln Ala Gln Leu Ala Cys 
1               5                   10                  15      


Thr His 
        


<210> 16
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Ala Gly Val Val Cys Ala Thr Pro Glu Trp Thr Trp Asp Pro Ala Cys 
1               5                   10                  15      


Ala Thr 
        


<210> 17
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Ala Gly Leu Leu Cys Ala Pro Ser Leu Asp Pro Asp Tyr Ile Leu Cys 
1               5                   10                  15      


Asp Gln 
        


<210> 18
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Ala Gly Leu Leu Cys Glu Pro Trp Pro Pro Thr Ala Glu Ser Ile Cys 
1               5                   10                  15      


Arg Ser 
        


<210> 19
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Ala Gly Pro Pro Tyr Thr Val Phe Val His Leu 
1               5                   10      


<210> 20
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Ala Gly Tyr Cys Ile Ser Asp Tyr Ile Asp Pro Cys His 
1               5                   10              


<210> 21
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Ala Gly Pro Cys Ile Ser Asp Tyr Phe Asp Pro Cys His 
1               5                   10              


<210> 22
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Ala Gly Leu Cys Pro Glu Leu Pro His Cys 
1               5                   10  


<210> 23
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Ala Gly Pro Cys Pro Glu Leu Pro His Cys Thr Tyr 
1               5                   10          


<210> 24
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> N-term acetylated

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Lys-(Propargylacetyl)

<220>
<223> C-term amidated

<400> 24
Ala Gly Tyr Val Cys Asp Pro Ala Gly Pro Asn Cys Trp Ala Ser Gly 
1               5                   10                  15      


Gly Ser Gly Gly Ser Gly Gly Lys 
            20                  


<210> 25
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> N-term acetylated

<220>
<221> MOD_RES
<222> (27)..(27)
<223> Lys-(Propargylacetyl)

<220>
<223> C-term amidated

<400> 25
Ala Gly Val Trp Cys Gly Asp Glu Thr Leu Pro Pro Ser Ile Cys Phe 
1               5                   10                  15      


Arg Ser Gly Gly Ser Gly Gly Ser Gly Gly Lys 
            20                  25          


<210> 26
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> N-term acetylated

<220>
<223> C-term amidated

<400> 26
Ala Gly Tyr Val Cys Asp Pro Ala Gly Pro Asn Cys Trp Ala Ser Gly 
1               5                   10                  15      


Gly Ser Gly Gly Ser Gly Gly Lys 
            20                  


<210> 27
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> N-term acetylated

<220>
<223> C-term amidated

<400> 27
Ala Gly Val Trp Cys Gly Asp Glu Thr Leu Pro Pro Ser Ile Cys Phe 
1               5                   10                  15      


Arg Ser Gly Gly Ser Gly Gly Ser Gly Gly Lys 
            20                  25          


<210> 28
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Ala Gly Leu Tyr Val Ser Pro Trp Pro Pro Thr Ala Glu Ser Thr Ala 
1               5                   10                  15      


Ile Ile 
        


<210> 29
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Ala Gly Leu Tyr Val Ser Pro Trp Pro Pro Thr Ala Glu Ser Thr Ala 
1               5                   10                  15      


Val Leu 
        


<210> 30
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Ala Gly Leu His Val Tyr Pro Trp Pro Pro Thr Ala Glu Ser Thr Ala 
1               5                   10                  15      


Tyr Leu 
        


<210> 31
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Ala Gly Ala Tyr Val Phe Pro Trp Pro Pro Thr Ala Glu Ser Thr Val 
1               5                   10                  15      


Thr Leu 
        


<210> 32
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (15)..(18)
<223> Any amino acid

<400> 32
Ala Gly Xaa Xaa Xaa Xaa Pro Trp Pro Pro Thr Ala Glu Ser Xaa Xaa 
1               5                   10                  15      


Xaa Xaa 
        


